Ignite Creation Date:
2024-05-06 @ 6:00 PM
Last Modification Date:
2024-10-26 @ 2:39 PM
Study NCT ID:
NCT05500807
Status:
RECRUITING
Last Update Posted:
2023-03-01
First Post:
2022-08-12
Brief Title:
Emicizumab for Severe Von Willebrand Disease VWD and VWDHemophilia A
Sponsor:
Bleeding and Clotting Disorders Institute Peoria Illinois
Organization:
Bleeding and Clotting Disorders Institute Peoria Illinois
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-11-01
Start Date Type:
ACTUAL
Primary Completion Date:
2025-11
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-03
Completion Date Type:
ESTIMATED
First Submit Date:
2022-08-12
First Submit QC Date:
August 12 2022
Study First Post Date:
2022-08-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-02-27
Last Update Post Date:
2023-03-01
Last Update Post Date Type:
ACTUAL